LNA-modified oligonucleotides effectively drive intramolecular-stable hairpin to intermolecular-duplex state

被引:16
作者
Kaur, Harleen
Wengel, Jesper
Maiti, Souvik
机构
[1] CSIR, Inst Genom & Integrat Biol, Delhi 110007, India
[2] Univ So Denmark, Nucl Acid Ctr, Dept Chem, DK-5230 Odense M, Denmark
关键词
locked nucleic acid; hairpin trapping; therapeutic oligonucleotide;
D O I
10.1016/j.bbrc.2006.10.155
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sequence-specific hybridization of antisense and antigene agent to the target nucleic acid is an important therapeutic strategy to modulate gene expression. However, efficiency of such agents falls due to inherent intramolecular-secondary-structures present in the target that pose competition to intermolecular hybridization by complementary antisense/antigene agent. Performance of these agents can be improved by employing structurally modified complementary oligonucleotides that efficiently hybridize to the target and force it to transit from an intramolecular-structured-state to an intermolecular-duplex state. In this study, the potential of variably substituted locked nucleic acid-modified oligonucleotides (8mer) to hybridize and disrupt highly stable, secondary structure of nucleic acid has been biophysically characterized and compared with the conventionally used unmodified DNA oligonucleotides. The target here is a stem-loop hairpin oligonucleotide-a structure commonly present in most structured-nucleic acids and known to exhibit an array of biological functions. Using fluorescence-based studies and EMSA we prove that LNA-modified oligonucleotides hybridize to the target hairpin with higher binding affinity even at lower concentration and subsequently, force it to assume a duplex conformation. LNA-modified oligonucleotides may thus, prove as potential therapeutic candidates to manipulate gene expression by disruption of biologically relevant nucleic acid secondary structure. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:118 / 122
页数:5
相关论文
共 23 条
[1]   Antisense therapeutics: is it as simple as complementary base recognition? [J].
Agrawal, S ;
Kandimalla, ER .
MOLECULAR MEDICINE TODAY, 2000, 6 (02) :72-81
[2]   Oligonucleotide analogue interference with the HIV-1 Tat protein-TAR RNA interaction [J].
Arzumanov, A ;
Walsh, AP ;
Liu, XH ;
Rajwanshi, VK ;
Wengel, J ;
Gait, MJ .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2001, 20 (4-7) :471-480
[3]   RNA interference in mammalian cells by chemically-modified RNA [J].
Braasch, DA ;
Jensen, S ;
Liu, YH ;
Kaur, K ;
Arar, K ;
White, MA ;
Corey, DR .
BIOCHEMISTRY, 2003, 42 (26) :7967-7975
[4]   Oligonucleotide directed misfolding of RNA inhibits Candida albicans group I intron splicing [J].
Childs, JL ;
Disney, MD ;
Turner, DH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (17) :11091-11096
[5]   Design and characterization of decoy oligonucleotides containing locked nucleic acids [J].
Crinelli, R ;
Bianchi, M ;
Gentilini, L ;
Magnani, M .
NUCLEIC ACIDS RESEARCH, 2002, 30 (11) :2435-2443
[6]   Implications of high-affinity hybridization by locked nucleic acid oligomers for inhibition of human telomerase [J].
Elayadi, AN ;
Braasch, DA ;
Corey, DR .
BIOCHEMISTRY, 2002, 41 (31) :9973-9981
[7]   In vivo tumor growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotides [J].
Fluiter, K ;
ten Asbroek, ALMA ;
de Wissel, MB ;
Jakobs, ME ;
Wissenbach, M ;
Olsson, H ;
Olsen, O ;
Oerum, H ;
Baas, F .
NUCLEIC ACIDS RESEARCH, 2003, 31 (03) :953-962
[8]   Nuclease stability of LNA oligonucleotides and LNA-DNA chimeras [J].
Frieden, M ;
Hansen, HF ;
Koch, T .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2003, 22 (5-8) :1041-1043
[9]   Antisense knockdown of PKC-α using LNA-oligos [J].
Hansen, JB ;
Westergaard, M ;
Thrue, CA ;
Giwercman, B ;
Oerum, H .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2003, 22 (5-8) :1607-1609
[10]  
Kalota A, 2006, HANDB EXP PHARM, V173, P173